Sign in
4/A

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-020817

Chief Commercial Officer acquired 7,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silvestro Stephen L Chief Commercial Officer 2024-02-15 Grant or award +7,750 16,906 D
Loading xslF345X05/wk-form4a_1715045531.xml…